Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Other Working Capital Changes (2016 - 2025)

Sanara MedTech (SMTI) has disclosed Other Working Capital Changes for 15 consecutive years, with -$84859.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Working Capital Changes rose 36.28% year-over-year to -$84859.0, compared with a TTM value of $321461.0 through Sep 2025, up 156.79%, and an annual FY2024 reading of $515496.0, up 203.89% over the prior year.
  • Other Working Capital Changes was -$84859.0 for Q3 2025 at Sanara MedTech, down from -$83432.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $767833.0 in Q4 2024 and bottomed at -$585096.0 in Q4 2021.
  • Average Other Working Capital Changes over 5 years is -$23341.9, with a median of -$83432.0 recorded in 2025.
  • The sharpest move saw Other Working Capital Changes skyrocketed 5596.81% in 2021, then plummeted 534.07% in 2023.
  • Year by year, Other Working Capital Changes stood at -$585096.0 in 2021, then skyrocketed by 159.75% to $349582.0 in 2022, then crashed by 189.74% to -$313702.0 in 2023, then skyrocketed by 344.77% to $767833.0 in 2024, then tumbled by 111.05% to -$84859.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for SMTI at -$84859.0 in Q3 2025, -$83432.0 in Q2 2025, and -$278081.0 in Q1 2025.